The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation. (2019)
Attributed to:
Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41590-019-0352-y
PubMed Identifier: 30936493
Publication URI: http://europepmc.org/abstract/MED/30936493
Type: Journal Article/Review
Volume: 20
Parent Publication: Nature immunology
Issue: 5
ISSN: 1529-2908